MarketsnMarkets

This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector.

This analysis examines the historical and forecast performance for BMS in the prescription pharmaceutical sector.

This analysis examines the historical and forecast performance for Boehringer Ingelheim in the Rx pharmaceutical sector.

This analysis examines the historical and forecast performance for Astellas in the Rx pharmaceutical sector.

The report forecasts and analyzes the future impact of the health reforms on the U.S. healthcare industry.

This report analyses and apportions both power and gas volumes and sites in the UK B2B market into Datamonitor's segmentation model

China’s turpentine mainly refers to gum turpentine owing to the small amount of crude sulphate turpentine and wood turpentine. China has abundant pine resources, which provides great potential for oleoresin supply.

Datamonitor forecasts the inflammatory bowel disease market to become increasingly competitive with the anticipated launch of seven new products, spanning five drug classes from 2010 to 2019.

Sales of multiple sclerosis disease-modifying therapies exceeded $6.0 billion in 2008 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

The database is an invaluable resource for understanding the dynamics of the rapidly growing card markets in Latin America.